European Heart Journal
Publication Venue For
Alirocumab after acute coronary syndrome in patients with a history of heart failure.
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering:ODYSSEY OUTCOMES trial
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: Prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
Salt and cardiovascular disease: Insufficient evidence to recommend low sodium intake
Hypertensive coronary microvascular dysfunction: A subclinical marker of end organ damage and heart failure
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: An ODYSSEY OUTCOMES trial analysis
Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: A propensity-matched analysis of Medicare claims data
Effects of alirocumab on types of myocardial infarction: Insights from the ODYSSEY OUTCOMES trial
Cardiovascular outcome trials in patients with chronic kidney disease: Challenges associated with selection of patients and endpoints
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study
Take a blood pressure pill or benefit from renal denervation?
Final Farewell to Alberto Zanchetti MD.
The circadian clock in cardiovascular regulation and disease: Lessons from the Nobel Prize in Physiology or Medicine 2017
Acellular therapeutic approach for heart failure: In vitro production of extracellular vesicles from human cardiovascular progenitors
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials
International recommendations for electrocardiographic interpretation in athletes
Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: Update 2016
Global position paper on cardiovascular regenerative medicine
The technical report on sodiumintake and cardiovascular disease in low- and middleincome countries by the joint working group of theWorld Heart Federation, the European Society of Hypertension and the European Public Health Association
Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes andmultivessel coronary artery disease with or without chronic kidney disease
Valvular heart disease in older adults: Seeking an ounce of prevention
Cardiac structure and function and leisure-time physical activity in the elderly: The Atherosclerosis Risk in Communities Study
The TACTICS initiative: Time for a Global Alliance on Cardiovascular Regenerative Medicine
CardioPulse. The SPRINT trial results
The SPRINT trial results
Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction
Mechanical Dyssynchrony: A Risk Factor but not a Target
Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: First clinical case report
Alcohol consumption and risk of heart failure: The Atherosclerosis Risk in Communities Study
Function over form? Assessing the left atrium in heart failure
Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: A translational experience
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction: A forest of a variety of trees
A rare coronary anomaly: Origin of the right coronary artery from the left ventricular outflow tract
Combined intracardiac and epicardial device closure of a large left ventricular pseudoaneurysm
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: Findings from post hoc propensity-matched analysis of the AFFIRM trial
Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency
Third universal definition of myocardial infarction
Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction.
Physiological concentration of glutamine increases exogenous fatty acid utilization in the ex vivo working heart: role of the hexosamine biosynthetic pathway
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: The MADIT-CRT trial
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction
Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: Potential mechanistic insights from epidemiological data
Boomerang-shaped heart in isolated dextroversion
A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: A propensity-matched study
Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: A population-based prospective study of middle-aged and elderly men
Dipyridamole promotes ischemia-induced angiogenesis and tissue blood flow in critical limb ischemia througha PKA dependent nitric oxide pathway
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure
Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients
Digoxin and reduction in mortality in systolic and diastolic heart failure at low serum digoxin concentrations 
Heart failure, chronic diuretic use, and increase in mortality and hospitalization: An observational study using propensity score methods
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study
The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart
Digoxin and reduction in mortality and hospitalization in heart failure: A comprehensive post hoc analysis of the DIG trial
Skeletal myoblast transplantation through a catheter-based coronary sinus approach: An effective means of improving function of infarcted myocardium
Hormone treatment - Misconceptions and agreements  (multiple letters)
Hormone treatment--misconceptions and agreements.
Intravenous NPA for the treatment of infarcting myocardium early: InTIME-II, a double-blind comparison on of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
Simultaneous imaging of transmembrane potential and intracellular calcium in myocyte cultures
Abciximab therapy in percutaneous intervention: economic issues in the United States.
. 19 Suppl D:D52-D58.
Increased platelet activation and fibrinogen in Asian Indians. Potential implications for coronary risk
Single right coronary artery assessed by contrast angiography and transoesophageal echocardiography
Triiodothyronine therapy in open-heart surgery: From hope to disappointment
Clinical use of automatic implantable defibrillators.
. 8 Suppl D:143-147.
Clinical use of automatic implantable defibrillators
Protective effects of cardioplegia on diastolic function of hypertrophied rat hearts after hypothermic ischaemic arrest.
. 5 Suppl F:347-353.
Protective effects of cardioplegia on diastolic function of hypertrophied rat hearts after hypothermic ischaemic arrest
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)